Commentary & Perspectives

SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer

Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

Share

Research on hormone replacement therapy for breast cancer was featured at the 2025 San Antonio Breast Cancer Symposium, presented by experts Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH. They highlighted key findings that could influence treatment approaches and patient care, addressing the implications for hormone therapy in breast cancer survivors and the ongoing inquiry into safety and efficacy. This symposium serves as a pivotal platform for the latest advancements in breast cancer research.

Original Source(s)

SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer

  • March 17, 2026

Related Content

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

SABCS 2025 Highlights: Patient Perspective

Lindsay Northrop, breast cancer survivor and patient advocate at Dana-Farber, talks with Harold Burstein, MD, PhD, about how recent advances in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium will impact patient care.

  • March 17, 2026

SABCS Highlights: Advances in Oral SERD's for Breast Cancer

Harold Burstein, MD, PhD, and Rinath M. Jeselsohn, MD, discuss the lidERA, evERA, and EMBER-3 trials researching oral selective estrogen receptor degraders (SERDs).

  • March 17, 2026